Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer

Cancer Biomarkers

Volumn 15, Issue 2, 2015, Pages 195-201

  Ghanbari, Reza ^a,b   Mosakhani, Neda ^c   Asadi, Jahanbakhsh ^a   Nouraee, Nazila ^d   Mowla, Seyed Javad ^d   Poustchi, Hossein ^e   Malekzadeh, Reza ^b   Knuutila, Sakari ^c  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TARBIAT MODARES UNIVERSITY   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diagnosis; microarray; Profiling

Indexed keywords

MICRORNA; MICRORNA 1295B 3P; MICRORNA 4478; UNCLASSIFIED DRUG; MIRN-1295 MICRORNA, HUMAN; MIRN-4478 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; RNA ISOLATION; VALIDATION STUDY; AGED; CASE CONTROL STUDY; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84925345895     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-140453     Document Type: Article

References (31)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward and D. Forman, Global cancer statistics, CA: a cancer journal for clinicians 61 (2011), 69-90.
2. R. Siegel, D. Naishadham and A. Jemal, Cancer statistics, 2012, CA: a cancer journal for clinicians 62 (2012), 10-29.
3. R.A. Smith, D. Brooks, V. Cokkinides, D. Saslow and O.W. Brawley, Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening, CA: a cancer journal for clinicians 63 (2013), 88-105.
4. J.M. Rhodes, Colorectal cancer screening in the UK: Joint Position Statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland, Gut 46 (2000), 746-748.
5. D.A. Lieberman, Clinical practice. Screening for colorectal cancer, The New England journal of medicine 361 (2009), 1179-1187.
6. S. Winawer, R. Fletcher, D. Rex, J. Bond, R. Burt, J. Ferrucci, T. Ganiats, T. Levin, S. Woolf, D. Johnson, L. Kirk, S. Litin and C. Simmang, Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence, Gastroenterology 124 (2003), 544-560.
7. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell 116 (2004), 281-297.
8. E. Bandres, E. Cubedo, X. Agirre, R. Malumbres, R. Zarate, N. Ramirez, A. Abajo, A. Navarro, I. Moreno, M. Monzo and J. Garcia-Foncillas, Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues, Molecular cancer 5 (2006), 29.
9. J.M. Cummins, Y. He, R.J. Leary, R. Pagliarini, L.A. Diaz, Jr., T. Sjoblom, O. Barad, Z. Bentwich, A.E. Szafranska, E. Labourier, C.K. Raymond, B.S. Roberts, H. Juhl, K.W. Kinzler, B. Vogelstein and V.E. Velculescu, The colorectal microRNAome, Proceedings of the National Academy of Sciences of the United States of America 103 (2006), 3687-3692.
10. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz and T.R. Golub, MicroRNA expression profiles classify human cancers, Nature 435 (2005), 834-838.
11. M.Z. Michael, O.C. SM, N.G. van Holst Pellekaan, G.P. Young and R.J. James, Reduced accumulation of specific microRNAs in colorectal neoplasia, Molecular cancer research: MCR 1 (2003), 882-891.
12. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng and X. Du, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. International journal of cancer, Journal international du cancer 127 (2010), 118-126.
13. Y. Xi, G. Nakajima, E. Gavin, C.G. Morris, K. Kudo, K. Hayashi and J. Ju, Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples, RNA 13 (2007), 1668-1674.
14. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin and M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences of the United States of America 105 (2008), 10513-10518.
15. M. Kalimutho, G. Del Vecchio Blanco, S. Di Cecilia, P. Sileri, M. Cretella, F. Pallone, G. Federici and S. Bernardini, Differential expression of miR-144∗as a novel fecal-based diagnostic marker for colorectal cancer, Journal of gastroenterology 46 (2011), 1391-1402.
16. F.E. Ahmed, C.D. Jeffries, P.W. Vos, G. Flake, G.J. Nuovo, D.R. Sinar, W. Naziri and S.P. Marcuard, Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue, Cancer genomics & proteomics 6 (2009), 281-295.
17. M. Brittan and N.A. Wright, Stem cell in gastrointestinal structure and neoplastic development, Gut 53 (2004), 899-910.
18. A. Loktionov, Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening, International journal of cancer, Journal international du cancer 120 (2007), 2281-2289.
19. D.A. Ahlquist, Molecular detection of colorectal neoplasia, Gastroenterology 138 (2010), 2127-2139.
20. T. Nagasaka, N. Tanaka, H.M. Cullings, D.S. Sun, H. Sasamoto, T. Uchida, M. Koi, N. Nishida, Y. Naomoto, C.R. Boland, N. Matsubara and A. Goel, Analysis of fecal DNA methylation to detect gastrointestinal neoplasia, Journal of the National Cancer Institute 101 (2009), 1244-1258.
21. E.E. Deschner, Early proliferative changes in gastrointestinal neoplasia, The American journal of gastroenterology 77 (1982), 207-211.
22. F.E. Ahmed, N.C. Ahmed, P.W. Vos, C. Bonnerup, J.N. Atkins, M. Casey, G.J. Nuovo, W. Naziri, J.E. Wiley, H. Mota and R.R. Allison, Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I, Proof of principle, Cancer genomics & proteomics 10 (2013), 93-113.
23. C.W. Wu, S.S. Ng, Y.J. Dong, S.C. Ng, W.W. Leung, C.W. Lee, Y.N. Wong, F.K. Chan, J. Yu and J.J. Sung, Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps, Gut 61 (2012), 739-745.
24. A. Link, F. Balaguer, Y. Shen, T. Nagasaka, J.J. Lozano, C.R. Boland and A. Goel, Fecal MicroRNAs as novel biomarkers for colon cancer screening, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19 (2010), 1766-1774.
25. Y. Koga, M. Yasunaga, A. Takahashi, J. Kuroda, Y. Moriya, T. Akasu, S. Fujita, S. Yamamoto, H. Baba and Y. Matsumura, MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening, Cancer Prev Res (Phila) 3 (2010), 1435-1442.
26. J.M. Li, R.H. Zhao, S.T. Li, C.X. Xie, H.H. Jiang, W.J. Ding, P. Du, W. Chen, M. Yang and L. Cui, Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer, Saudi medical journal 33 (2012), 24-29.
27. O.A. Berillo, A.S. Issabekova, M. Régnier and A.T. Ivashchenko, Characteristics of binding sites of intergenic, intronic and exonic miRNAs with mRNAs of oncogenes coding intronic miRNAs, African Journal of Biotechnology 12 (2013), 8.
28. A.J. Wilson, D.S. Byun, S. Nasser, L.B. Murray, K. Ayyanar, D. Arango, M. Figueroa, A. Melnick, G.D. Kao, L.H. Augenlicht and J.M. Mariadason, HDAC4 promotes growth of colon cancer cells via repression of p21, Molecular biology of the cell 19 (2008), 4062-4075.
29. J.E. Bolden, M.J. Peart and R.W. Johnstone, Anticancer activities of histone deacetylase inhibitors. Nature reviews, Drug discovery 5 (2006), 769-784.
30. A.J. Wilson, D.S. Byun, N. Popova, L.B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L.H. Augenlicht and J.M. Mariadason, Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer, The Journal of biological chemistry 281 (2006), 13548-13558.
31. M.L. Slattery, E. Wolff, M.D. Hoffman, D.F. Pellatt, B. Milash and R.K. Wolff, MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype, Genes, chromosomes & cancer 50 (2011), 196-206.